TherapeuticsMD, Inc. (TXMD) quarterly income statement — complete revenue, gross profit & net income history
TherapeuticsMD, Inc. (TXMD) annual income statement — 30-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 869K | 724K | 893K | 784K | 952K | 393K | 667K | 547K | 234K | 313K | 502K | -53K | 437K | 416K | 1.15M | 20.92M | 28.56M | 19.33M | 18.68M | 25.41M |
| Revenue Growth % | -8.72% | 84.22% | 33.88% | 43.33% | 306.84% | 25.56% | 32.87% | 1132.08% | -46.45% | -24.76% | -56.42% | -100.25% | -98.47% | -97.85% | -93.83% | -17.67% | 24.17% | -2.68% | -17.27% | 31.35% |
| Cost of Goods Sold | 329K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 637K | 0 | 0 | 0 | 3.43M | 3.79M | 4.74M | 4.86M | 4.74M | 5.28M |
| COGS % of Revenue | 37.86% | - | - | - | - | - | - | - | - | - | 126.89% | - | - | - | 298.09% | 18.11% | 16.6% | 25.14% | 25.36% | 20.79% |
| Gross Profit | 540K | 724K | 893K | 784K | 952K | 393K | 667K | 547K | 234K | 313K | -135K | -53K | 437K | 416K | -2.28M | 17.13M | 23.82M | 14.47M | 13.94M | 20.12M |
| Gross Margin % | 62.14% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | -26.89% | 100% | 100% | 100% | -198.09% | 81.89% | 83.4% | 74.86% | 74.64% | 79.21% |
| Gross Profit Growth % | -43.28% | 84.22% | 33.88% | 43.33% | 306.84% | 25.56% | 594.07% | 1132.08% | -46.45% | -24.76% | 94.08% | -100.31% | -98.17% | -97.13% | -116.37% | -14.88% | 26.24% | -4.65% | -17.98% | 25.28% |
| Operating Expenses | 1.34M | 1.45M | 2.39M | 1.61M | 1.65M | 1.59M | 979K | 1.68M | 3.02M | 1.46M | 1.48M | 1.72M | 2.91M | 3.08M | -63.34M | 37.88M | 42.66M | 40.7M | 49.33M | 60.05M |
| OpEx % of Revenue | 154.55% | 199.86% | 267.53% | 205.87% | 173% | 403.56% | 146.78% | 307.31% | 1291.88% | 464.86% | 294.02% | -3245.28% | 665.68% | 741.11% | -5498% | 181.08% | 149.37% | 210.53% | 264.12% | 236.34% |
| Selling, General & Admin | 1.58M | 1.35M | 2.29M | 1.52M | 1.55M | 1.49M | 879K | 1.58M | 1.58M | 1.32M | 1.48M | 1.59M | 2.78M | 3.06M | -59.24M | 36.76M | 41.08M | 39.3M | 47.91M | 58.44M |
| SG&A % of Revenue | 181.47% | 186.88% | 256.66% | 193.62% | 162.92% | 379.39% | 131.78% | 289.76% | 676.07% | 422.36% | 294.02% | -3000% | 636.38% | 734.62% | -5142.8% | 175.76% | 143.84% | 203.29% | 256.52% | 230.02% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.09M | 1.11M | 1.58M | 1.4M | 1.42M | 1.6M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -355.21% | 5.32% | 5.53% | 7.24% | 7.6% | 6.32% |
| Other Operating Expenses | -234K | 94K | 97K | 96K | 96K | 95K | 100K | 96K | 1000K | 133K | 0 | 130K | 128K | 27K | 1000K | 0 | -16K | 0 | 0 | 0 |
| Operating Income | -803K | -723K | -1.5M | -830K | -695K | -1.19M | -312K | -1.13M | -2.79M | -1.14M | -1.61M | -1.77M | -2.47M | -2.67M | 111.58M | -20.75M | -18.84M | -26.23M | -35.39M | -39.92M |
| Operating Margin % | -92.41% | -99.86% | -167.53% | -105.87% | -73% | -303.56% | -46.78% | -207.31% | -1191.88% | -364.86% | -320.92% | 3345.28% | -565.68% | -641.11% | 9685.59% | -99.19% | -65.97% | -135.67% | -189.48% | -157.13% |
| Operating Income Growth % | -15.54% | 39.4% | -379.49% | 26.81% | 75.08% | -4.47% | 80.63% | 36.04% | -12.82% | 57.18% | -101.44% | 91.45% | 86.88% | 89.83% | 415.26% | 48.03% | 46.44% | 10.41% | -2.27% | -59.85% |
| EBITDA | -474K | -398K | -590K | -734K | -599K | -1.1M | -212K | -1.04M | -2.61M | -1.01M | -974K | -1.64M | -2.34M | -2.64M | 109.59M | -19.71M | -17.8M | -25.13M | -34.39M | -38.89M |
| EBITDA Margin % | -54.55% | -54.97% | -66.07% | -93.62% | -62.92% | -279.39% | -31.78% | -189.76% | -1114.96% | -322.36% | -194.02% | 3101.89% | -536.16% | -634.62% | 9513.02% | -94.24% | -62.31% | -129.98% | -184.12% | -153.08% |
| EBITDA Growth % | 20.87% | 63.75% | -178.3% | 29.29% | 77.04% | -8.82% | 78.23% | 36.86% | -11.35% | 61.78% | -100.89% | 91.66% | 86.83% | 89.49% | 418.67% | 49.31% | 47.87% | 11.08% | -2.42% | -62.36% |
| D&A (Non-Cash Add-back) | 329K | 325K | 906K | 96K | 96K | 95K | 100K | 96K | 180K | 133K | 637K | 129K | 129K | 27K | -1.99M | 1.03M | 1.05M | 1.1M | 1M | 1.03M |
| EBIT | -803K | -723K | -4.15M | 53K | 547K | -1.19M | -1.07M | -564K | -1.04M | -809K | -1.5M | -1.41M | -2.37M | -2.26M | -34.81M | -20.93M | -14.86M | -17.88M | -41.58M | -41.38M |
| Net Interest Income | 69K | 41K | -1K | -3K | -2K | 27K | 0 | -3K | -5K | 0 | 215K | -20K | -45K | -50K | -34.17M | 2.58M | -3.77M | -5.36M | -7.58M | -7.52M |
| Interest Income | 69K | 41K | 0 | 0 | 0 | 29K | 0 | 0 | 0 | 0 | 300K | 0 | 0 | 0 | 0 | 4.83M | 0 | 0 | 0 | - |
| Interest Expense | 0 | 0 | 1K | 3K | 2K | 2K | 0 | 3K | 5K | 0 | 85K | 20K | 45K | 50K | 34.17M | 2.25M | 3.77M | 5.36M | 7.58M | 7.52M |
| Other Income/Expense | 967K | 826K | 916K | 880K | 1.24M | 525K | 395K | 567K | 1.74M | 333K | 27K | 339K | 58K | 357K | -100.52M | 5.86M | 4.52M | -22.79M | -7.57M | -7.5M |
| Pretax Income | 164K | 103K | -580K | 50K | 545K | -668K | 83K | -567K | -1.05M | -809K | -1.58M | -1.43M | -2.41M | -2.31M | -33.51M | -14.89M | -14.32M | -49.02M | -42.96M | -47.42M |
| Pretax Margin % | 18.87% | 14.23% | -64.95% | 6.38% | 57.25% | -169.97% | 12.44% | -103.66% | -448.72% | -258.47% | -315.54% | 2705.66% | -552.4% | -555.29% | -2908.94% | -71.19% | -50.15% | -253.56% | -230% | -186.65% |
| Income Tax | 0 | 0 | 32K | 0 | 0 | -32K | -31K | 0 | 0 | 0 | -43K | 0 | 0 | 0 | -290K | -260K | 550K | 22.79M | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | -5.52% | 0% | 0% | 4.79% | -37.35% | 0% | 0% | 0% | 2.71% | 0% | 0% | 0% | 0.87% | 1.75% | -3.84% | -46.49% | 0% | 0% |
| Net Income | 155K | 95K | -619K | 152K | 551K | -653K | 252K | -609K | -1.09M | -734K | -883K | -3.38M | -2.41M | -3.6M | -33.22M | -28.96M | 112.28M | -71.81M | -42.96M | -47.42M |
| Net Margin % | 17.84% | 13.12% | -69.32% | 19.39% | 57.88% | -166.16% | 37.78% | -111.33% | -465.81% | -234.5% | -175.9% | 6373.58% | -552.4% | -866.11% | -2883.77% | -138.48% | 393.13% | -371.45% | -230% | -186.65% |
| Net Income Growth % | -71.87% | 114.55% | -345.63% | 124.96% | 150.55% | 11.04% | 128.54% | 81.97% | 54.85% | 79.63% | 97.34% | 88.34% | -102.15% | 94.98% | 22.67% | 38.92% | 363.25% | -82.35% | -2.07% | -45.41% |
| Net Income (Continuing) | 164K | 103K | -612K | 50K | 545K | -636K | 114K | -567K | -1.05M | -809K | -1.54M | -1.43M | -2.41M | -2.31M | -33.22M | -14.63M | -14.87M | -17.88M | -42.96M | -47.42M |
| Discontinued Operations | -9K | -8K | -7K | 102K | 6K | -17K | 138K | -42K | -40K | 75K | 658K | -1000K | 0 | -1000K | 0 | -1000K | 1000K | -1000K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.01 | 0.01 | -0.05 | 0.01 | 0.05 | -0.06 | 0.02 | -0.05 | -0.09 | -0.06 | -0.08 | -0.32 | -0.24 | -0.37 | -3.55 | -3.13 | 12.39 | -8.34 | -5.03 | -5.62 |
| EPS Growth % | -73.4% | 114.51% | -344.29% | 126.2% | 155.56% | 5.83% | 128.59% | 84.38% | 62.5% | 83.78% | 97.84% | 89.78% | -101.94% | 95.56% | 29.42% | 44.31% | 329.02% | -47.09% | 31.47% | 6.02% |
| EPS (Basic) | 0.01 | 0.01 | -0.05 | 0.01 | 0.05 | -0.06 | 0.02 | -0.05 | -0.09 | -0.06 | -0.08 | -0.32 | -0.24 | -0.37 | -3.55 | -3.13 | 12.83 | -8.36 | -5.03 | -5.62 |
| Diluted Shares Outstanding | 11.64M | 11.64M | 11.57M | 11.57M | 11.57M | 11.55M | 11.53M | 11.53M | 11.53M | 11.53M | 11.53M | 10.7M | 10.22M | 9.75M | 9.37M | 9.26M | 9.06M | 8.61M | 8.55M | 8.44M |
| Basic Shares Outstanding | 11.57M | 11.57M | 11.57M | 11.57M | 11.57M | 11.55M | 11.53M | 11.53M | 11.53M | 11.53M | 11.53M | 10.7M | 10.22M | 9.75M | 9.37M | 9.25M | 8.75M | 8.59M | 8.55M | 8.44M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |